These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3862899)

  • 1. Risk of breast cancer to relatives of young breast cancer patients.
    Schwartz AG; King MC; Belle SH; Satariano WA; Swanson GM
    J Natl Cancer Inst; 1985 Oct; 75(4):665-8. PubMed ID: 3862899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations.
    Dite GS; Jenkins MA; Southey MC; Hocking JS; Giles GG; McCredie MR; Venter DJ; Hopper JL
    J Natl Cancer Inst; 2003 Mar; 95(6):448-57. PubMed ID: 12644538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease.
    Collaborative Group on Hormonal Factors in Breast Cancer
    Lancet; 2001 Oct; 358(9291):1389-99. PubMed ID: 11705483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timing of familial breast cancer in sisters.
    Rebora P; Czene K; Reilly M
    J Natl Cancer Inst; 2008 May; 100(10):721-7. PubMed ID: 18477799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age at onset as an indicator of familial risk of breast cancer.
    Claus EB; Risch NJ; Thompson WD
    Am J Epidemiol; 1990 Jun; 131(6):961-72. PubMed ID: 2188501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic information of a previously diagnosed sister is an independent prognosticator for a newly diagnosed sister with breast cancer.
    Lindström LS; Li J; Lee M; Einbeigi Z; Hartman M; Hall P; Czene K
    Ann Oncol; 2014 Oct; 25(10):1966-1972. PubMed ID: 25057175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of breast cancer risk in families of young breast cancer patients and controls.
    Schwartz AG; Kaufmann R; Moll PP
    Am J Epidemiol; 1991 Dec; 134(11):1325-34. PubMed ID: 1755446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practical guide for estimating risk for familial breast cancer.
    Ottman R; Pike MC; King MC; Henderson BE
    Lancet; 1983 Sep; 2(8349):556-8. PubMed ID: 6136703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of lung cancer among white and black relatives of individuals with early-onset lung cancer.
    Coté ML; Kardia SL; Wenzlaff AS; Ruckdeschel JC; Schwartz AG
    JAMA; 2005 Jun; 293(24):3036-42. PubMed ID: 15972566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial predisposition to breast cancer in a British population: implications for prevention.
    Pharoah PD; Lipscombe JM; Redman KL; Day NE; Easton DF; Ponder BA
    Eur J Cancer; 2000 Apr; 36(6):773-9. PubMed ID: 10762751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of familial breast cancer.
    Anderson DE; Badzioch MD
    Cancer; 1985 Jul; 56(2):383-7. PubMed ID: 4005803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between family history of cancer and breast cancer defined by estrogen and progesterone receptor status.
    Tutera AM; Sellers TA; Potter JD; Drinkard CR; Wiesner GL; Folsom AR
    Genet Epidemiol; 1996; 13(2):207-21. PubMed ID: 8722747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Family history and risk of breast cancer in New Zealand.
    McCredie M; Paul C; Skegg DC; Williams S
    Int J Cancer; 1997 Nov; 73(4):503-7. PubMed ID: 9389563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer risk estimates for family members of a population-based family registry for breast and ovarian cancer.
    Ziogas A; Gildea M; Cohen P; Bringman D; Taylor TH; Seminara D; Barker D; Casey G; Haile R; Liao SY; Thomas D; Noble B; Kurosaki T; Anton-Culver H
    Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):103-11. PubMed ID: 10667470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer in men: aspects of familial aggregation.
    Rosenblatt KA; Thomas DB; McTiernan A; Austin MA; Stalsberg H; Stemhagen A; Thompson WD; Curnen MG; Satariano W; Austin DF
    J Natl Cancer Inst; 1991 Jun; 83(12):849-54. PubMed ID: 2061945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Family history and oral contraceptives: unique relationships in breast cancer patients.
    Black MM; Kwon CS; Leis HP; Barclay TH
    Cancer; 1980 Dec; 46(12):2747-51. PubMed ID: 7448714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The genetic attributable risk of breast and ovarian cancer.
    Claus EB; Schildkraut JM; Thompson WD; Risch NJ
    Cancer; 1996 Jun; 77(11):2318-24. PubMed ID: 8635102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial breast cancer in a population-based series.
    Ottman R; Pike MC; King MC; Casagrande JT; Henderson BE
    Am J Epidemiol; 1986 Jan; 123(1):15-21. PubMed ID: 3940434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced DNA repair synthesis in healthy women having first degree relatives with breast cancer.
    Kovacs E; Almendral A
    Eur J Cancer Clin Oncol; 1987 Jul; 23(7):1051-7. PubMed ID: 3665990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.